Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part and have signed an approved consent form before any study-related procedures begin.
- People aged 18 to 75 years old at the time of the screening visit.
- People who have been clinically diagnosed with pancreatic cancer.
- People with a good to fully active physical functioning level, meaning they are either fully active or have only minor restrictions on physically demanding activity (this is measured by a standard scale called the ECOG score of 0 or 1).
- People with an expected survival time of at least 6 months.
- People without serious problems affecting their blood, heart, liver, kidneys, or blood clotting.
Who may not be able to join:
- People who have previously received a type of cancer therapy called an oncolytic virus treatment, or any other systemic (whole-body) treatment for pancreatic cancer.
- People who have previously had a stem cell transplant from a donor or an organ transplant.
- People whose immune systems are weakened or not functioning properly.
- People with a known dependency on alcohol or drugs.
- People who are pregnant or currently breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 020-83525210
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety and tolerability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.